Defunct Company
Total Trials
15
As Lead Sponsor
12
As Collaborator
3
Total Enrollment
1,802
NCT00974896
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2006
Completion: Apr 30, 2011
NCT00630552
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
Phase: Phase 1/2
Start: Jun 30, 2007
Completion: Apr 30, 2012
NCT00563680
QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors
Phase: Phase 2
Start: Oct 31, 2007
Completion: Aug 31, 2012
NCT00626106
QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Start: Mar 27, 2008
Completion: Sep 23, 2011
NCT00791154
QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer
Start: Dec 2, 2008
Completion: May 1, 2013
NCT00819169
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors
Start: Jan 16, 2009
Completion: Aug 10, 2011
NCT00807612
QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Start: Jan 31, 2009
Completion: Aug 31, 2010
NCT00813605
QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma
Start: Mar 31, 2009
Completion: Jun 30, 2012
NCT01061788
A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007
Role: Collaborator
Start: Apr 30, 2010
Completion: Dec 19, 2018
NCT01231347
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Phase: Phase 3
Start: Apr 7, 2011
Completion: Dec 12, 2012
NCT01708161
A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors
Start: Nov 27, 2012
Completion: Jun 1, 2017
NCT01856920
QUILT-3.006 for Recurrent Medullary Thyroid Cancer
Start: Mar 26, 2013
Completion: May 8, 2018
NCT02383498
QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma
Start: May 1, 2015
Completion: Sep 1, 2019
NCT03127098
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
Start: Jun 26, 2017
Completion: Dec 7, 2017